Controls

Journals

MBS collaboration with University of Maine to develop antibodies to Osteopontin for breast cancer study
http://www.ncbi.nlm.nih.gov/pubmed/18237408

MBS Strep. equi clone 04D11 is used by thought leader, Dr. John Timoney for Vaccine Paper
Affects of N-terminal variation in the SeM protein of Streptococcus equi

News on Myeloperoxidase in research, MBS has new clones specific for human MPO
http://www.ncbi.nlm.nih.gov/pubmed/17592500

 

Press

MBS Strep. equi reagents in a rapid test for Strangles
http://www.horsetalk.co.nz/news/2010/11/078.shtml

Maine Technology Institute grant awarded to MBS collaborator Dr. Robert Causey for disease surveillance
MTI Grant Recipiants 2010

MBS has a Multipure plate of antibodies recognizing VPAC-1 recently making news as a therapeutic target for patients undergoing chemotherapy
http://www.thrombogenics.com/html/pipeline6B.asp.

MBS collaborator Dr. Lucy Liaw discusses future potential for Osteopontin work
http://www.necn.com/Boston/Health/2009/10/20/Breast-cancer-may-be-able-to/1256073734.html

Dr. Lucy Liaw discusses Additional Research
http://www.wlbz2.com/news/article/174999/9/Blood-test-may-detect-risk-for-cancer

MBS developed the murine antibody model used in the production of Aveo Pharmaceutical’s therapeutic AV-299
http://investor.aveopharma.com/phoenix.zhtml?c=219651&p=irol-newsArticle&ID=1395204&highlight=

Preferred Partners

Linscott’s Directory
http://www.linscottsdirectory.com/